Inventor

Gary F. Gerard

Inventor
Frederick, MD, US

Overview

21→
Patents
1991–2018
Patent span
Chemistry
Primary field (CPC C)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes29%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms23%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture15%
C12YEnzymes15%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests9%
A61KPreparations for medical, dental or toiletry purposes3%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations3%
C07KPeptides2%
PatentTitleYear
9,862,938'Thermostable reverse transcriptases and uses thereof'20188,753,845'Thermostable reverse transcriptases and uses thereof'20148,043,816'Compositions and methods for temperature-dependent nucleic acid synthesis'20117,749,708'Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule'20107,579,155'Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule'20097,560,261'Nucleic acid sequences encoding CEL II endonuclease'20097,129,075'Isolated CEL II endonuclease'20067,115,406'Recombinant method for making RSV reverse transcriptases and mutants thereof'20067,078,208'Thermostable reverse transcriptases and uses thereof'20066,989,259'Recombinant methods for making reverse transcriptases and mutants thereof'20066,964,861'Enhanced in vitro recombinational cloning of using ribosomal proteins'20056,835,561'Composition of reverse transcriptases and mutants thereof'20046,830,902'Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis'20046,610,522'Cloned genes encoding reverse transcriptase lacking RNase H activity'20036,589,768'Cloned genes encoding reverse transcriptase lacking RNase H activity'20036,518,019'Compositions and methods for reverse transcription of nucleic acid molecules'20036,063,608'Cloned genes encoding reverse transcriptase lacking RNase H activity'20005,668,005'Cloned genes encoding reverse transcriptase lacking RNASE H activity'19975,405,776'Cloned genes encoding reverse transcriptase lacking RNase H activity'19955,244,797'Cloned genes encoding reverse transcriptase lacking RNase H activity'19935,017,492'Reverse transcriptase and method for its production'1991

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1991–2000Patents assigned to LIFE TECHNOLOGIES INC (5)· patent assignee history
1991–2018Based in Frederick, MD, US· patent location history
2003–2006Patents assigned to INVITROGEN CORP (9)· patent assignee history
2006–2010Patents assigned to TRANSGENOMIC INC (4)· patent assignee history
2011–2018Patents assigned to LIFE TECHNOLOGIES CORP (3)· patent assignee history
2014Patents assigned to DHARIWAL GULSHAN (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
INVITROGEN CORP92003–2006
LIFE TECHNOLOGIES INC51991–2000
TRANSGENOMIC INC42006–2010
LIFE TECHNOLOGIES CORP32011–2018
DHARIWAL GULSHAN12014
Locations
LocationPatentsSpan
Frederick, Maryland, US211991–2018